Results 101 to 110 of about 104,562 (257)

Inside the ‘Black Box’ of Pharmaceuticalisation: NICE, the Permissive Principle and the Case of Anticoagulants [PDF]

open access: yesSociol Health Illn
ABSTRACT Sociological interest in pharmaceuticalisation continues to grow, especially regarding the expansion of pharmaceutical use in society. This article presents the first major empirical study focusing on the directionality of pharmaceuticalisation by taking cost‐effectiveness assessment and regulation of anticoagulants in England by the National ...
Abraham J, Balendran G.
europepmc   +2 more sources

Effects of formulation types on pharmacodynamics of warfarin in patients with cerebral infarction and dysphagia

open access: yes, 2019
Young-Ji Kim,1,2 Jong-Woo Jeong,1 Youngshin Song,3 Tae-Sung Koo1 1Graduate School of New Drug Discovey and Development, Chungnam National University, Daejeon 305-764, Republic of Korea; 2Chungnam National University Hospital, Daejeon 305-764, Republic of
Jeong JW, Kim YJ, Koo TS, Song Y
core  

Charakterizace lidské warfarin reduktasy [PDF]

open access: yes, 2015
Univerzita Karlova v Praze Farmaceutická fakulta v Hradci Králové Katedra biochemických věd Kandidát: Simona Sokolová Školiteľ: PharmDr. Petra Malátková, Ph.D.
Sokolová, Simona
core  

Anticoagulant Rodenticides Contribute to a Decline in an Urban Carnivore

open access: yesAnimal Conservation, EarlyView.
Anticoagulant rodenticides (ARs) have been shown to negatively affect carnivores globally and are closely tied to human activity and development. We examined drivers of annual survival in bobcats persisting on a residentially developed barrier island over 16 years.
Meghan P. Keating   +7 more
wiley   +1 more source

Factors influencing medication knowledge and beliefs on warfarin adherence among patients with atrial fibrillation in China

open access: yes, 2017
Shujuan Zhao,1 Hongwei Zhao,1 Xianpei Wang,2 Chuanyu Gao,2 Yuhua Qin,1 Haixia Cai,1 Boya Chen,1 Jingjing Cao1 1Department of Pharmacy, 2Department of Cardiovascular Medicine, People’s Hospital of Henan Province, Zhengzhou, Henan, People’s ...
Zhao S   +7 more
core  

Nomenclature on Immune‐Mediated Drug Reactions: An EAACI Position Paper

open access: yesAllergy, EarlyView.
ABSTRACT Over the past several decades, there have been significant advances in our understanding of both immunological and pharmacological mechanisms of adverse drug reactions (ADRs). Immune‐mediated drug reactions (IMDRs) represent a small proportion of ADRs and are caused by a pathological activation of the immune system or inflammatory pathways ...
Maria J. Torres   +19 more
wiley   +1 more source

Formulary Considerations Related to Warfarin Interchangeability [PDF]

open access: yes, 2002
INTRODUCTIONFor years, Coumadin (DuPont Pharma Inc., Mississauga, Ontario) was the only warfarin product marketed in Canada. Recently, 2 additional warfarin products have received approval for sale in Canada: Taro-Warfarin (Taro Pharmaceuticals Inc ...
Shalansky, Karen F.   +3 more
core   +1 more source

Ischaemic Optic Neuropathy After Cardiac Surgery: A Systematic Review and Meta‐Analysis of Incidence and Risk Factors

open access: yesANZ Journal of Surgery, EarlyView.
Across 11 observational studies comprising 6 471 577 patients, the pooled incidence of ischaemic optic neuropathy after cardiac surgery was approximately 1.5 cases per 10 000 procedures. Coronary artery disease, peripheral vascular disease and anaemia were associated with increased odds of ION, although these findings should be interpreted in the ...
Daud Mutahar   +11 more
wiley   +1 more source

THE IL-6 DEPENDENT EFFECT OF ORAL WARFARIN IN HEART VALVE REPLACEMENT PATIENTS BY MEASURING INTERACTING CLINICAL AND DEMOGRAPHIC VARIABLES

open access: yesPakistan Armed Forces Medical Journal, 2016
Objective: To examine an inflammatory effect of warfarin and comparing with IL-6 levels along with different demographic and clinical variables. Study Design: Qusai experimental study.
Huma Shafiq   +4 more
doaj   +2 more sources

The Association of Warfarin Dosage in Clinical Use and Pharmacogenomics

open access: yes, 2007
研究背景 Warfarin是臨床上一個常用來治療及預防血液栓塞疾病的藥物。然而使用warfarin來治療有其風險存在,基本上是因為病患間的個體差異,可歸因於:基因變異、環境、疾病種類及嚴重程度所影響,而使得在劑量的調整相當重要,現在臨床上的作法是監測其國際標準凝血時間比值(INR, international normalized ratio)。為達個別化用藥的目的,我們將討論可能的影響因子。 研究方法 本研究共收集94年7月至94年10月台大醫院內科部有使用warfarin之門診病患,
吳孟霖, Wu, Meng-Lin
core  

Home - About - Disclaimer - Privacy